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Background: The analysis of a protein-expression pattern from tissue microarray (TMA) data 
will not immediately give an answer on synergistic or antagonistic effects between the observed 
proteins. But contrary to apparent first impression, it is possible to reveal those cooperative phe-
nomena from TMA data. The data is (1) preserving a lot of the original physiological information 
content and (2) because of minor variances between the tumor samples, contains several related 
slightly different biological states. We present here a largely assumption-free combinatorial 
analysis, related to correlation networks but with much less arbitrary constraints. A strong focus 
was put on the analysis of the basic data to analyze how the cooperative phenomena might be 
imprinted in the TMA data structure.
Results: The study design was based on two independent panels of 589 and 366 invasive breast 
cancer cases from different institutions, assembled on tissue microarrays. The combinatorial 
analysis generates an optimal rank ordering of protein-expression coherence. The outcome 
of the analysis corresponds to all the single observations scattered over several publications 
and integrates them in one context. This means all these scattered observations can also be 
deduced from one TMA experiment. A comprehensive statistical meta-analysis of the TMA 
data suggests the existence of a superposition of three basic coherence situations, and offers 
the opportunity to analyze these data properties with additional real-world data and synthetic 
data in more detail.
Conclusion: The presented algorithm gives molecular pathologists a tool to extract dependency 
information from TMA data. Beyond this practical benefit, some light was shed on how depen-
dency aspects might be imprinted into expression data. This will certainly foster the refinement 
of algorithms to reconstruct dependency networks. The implementation of the algorithm is at 
the moment not end-user suitable, but available on request.
Keywords: tissue microarrays, protein expression, dependency structure, breast cancer, 
 progression, algorithm, biological networks
Introduction
The cellular system consists of a large number and a wide variety of interacting 
molecules. At a certain moment, the presence and quantity or absence of molecules 
defines a certain state of the cell. This, for a certain state-typical expression pattern 
of molecules, is defined by a vast and in many aspects poorly understood network of 
interactions between these molecules.1 Types of molecules might be macromolecules 
like RNA, DNA, proteins, and also fragments thereof.
A broad spectrum of approaches has recently been proposed to unravel the depen-
dency structure between selected types of macromolecules.2 All those approaches 
are based in a certain way on expression data: means relative concentrations or 
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derivatives thereof.3 The analysis strategy may focus on more 
abstract aspects, like pure coherence of a certain (maybe 
itself abstract) class of events, eg, integrative networks,4 or on 
modeling dependency by similarity in expression patterns, eg, 
by correlations.5 Many approaches will be refined by  filtering 
for indirect effects, eg, partial correlations (basics and appli-
cation),3,6 and/or introduce more or less justified additional 
constraints like thresholds and additional downstream pro-
cedures.7 There are of course a lot more approaches, like 
modeling concrete biochemical reactions by differential 
equations,8 but we focus here on the fundamental aspects of 
(correlation-based) coexpression systems.
Most of the approaches are based on massive parallel 
measurements of molecular expression states, but few to no 
(biological) replicates. We center on the opposite, a limited 
number of proteins but with many biological replicates 
(several hundred). The measurements are based on immu-
nohistochemical data from tissue microarrays (TMAs), a 
data source that has not been used for advanced dependency 
studies up to now.
In the time of next-generation sequencing approaches, 
TMAs seem to be old-fashioned, but that is obviously not 
true. In contrast to gene-expression microarrays and next-
generation sequencing approaches, TMAs contain a lot more 
relevant information of the biological context. Looking on 
the sample source of procedures to measure expression 
rates, it can be noticed that they are based mostly on tissue 
extracts. TMAs in contrast preserve the tissues and therefore 
expose additional spatial and morphological information.9–11 
Moreover, TMAs measure proteins, which define more reli-
ably the physiological (steady state) situation of a cell type 
in a preserved tissue. At present, this technique is used to 
define and apply characteristic patterns of marker proteins for 
diagnostic purposes.12 Some other studies, showing the power 
of TMAs in the determination of prognostic and predictive 
markers in breast cancer, are reviewed in Chatterjee et al13 
and Packeisen et al.11 However, so far most studies have not 
considered the potential of TMAs to characterize more com-
plex (de)regulation mechanisms in cancer tissues. Instead, 
they were considered only as an approach complementary 
to expression microarrays.14,15 This situation inspired us to 
analyze the basic properties of TMA data in more depth.
The evaluation of the TMA is not only based on the 
measured protein signal strength but also on additional infor-
mation like localization (which cellular compartment or area 
of the extracellular matrix is stained), morphology  (tissue/
cellular architecture), and cellular neighborhood (which cell 
types are present at all). So the TMA technique provides 
a number of factors that add more specificity to the analyzed 
(patho)physiological situation. This will implicitly reduce the 
combinatorial complexity of presumed protein dependencies. 
With TMAs, we are analyzing more dependencies that truly 
exist in the experimental situation we are interested in, and 
avoid facing the task of filtering out a lot of the hypothetical 
but not implemented dependencies of the analyzed biological 
system. Of course, there are also drawbacks. The training 
of the pathologist doing the evaluations has a major impact 
on the quality of the results. The sensitivity of the TMAs 
might be limited for certain proteins, which will result in an 
underestimation of those proteins.
So, how are we utilizing existing concepts in the 
analysis of TMA data? The methodological approaches 
in expression-data analysis use at the first step real-scale 
data and the Pearson correlation, but very early switch to 
binary or nominal scale data, so losing quality and infor-
mation content. The correlation step is more or less used 
as a feasible proximity measure, but not further questioned 
concerning the process properties. We perform here similar 
to Langfelder et al.16 Due to the complexity of the result-
ing correlation space, and the need to get the correlation 
values ordered, this approach uses additional threshold or 
filtering procedures and/or is simplifying the scale of the 
data (a “binary” concept). But this simplification appears 
to be highly questionable. Most of the expression values 
populate a very narrow expression range. Differences might 
be found not by discriminating between signal strength, 
but by finding unique compositions of factors making up 
a certain expression module. So we switch at that point to 
a more data-driven approach. We employ a combinatorial 
optimization procedure, and try to find the best configura-
tion of dependencies concerning two selected subgroups 
of factors. The concept allows intermediate states, and the 
model is not limited to a certain type of network structure 
or biological data.
To give the analysis some statistical importance, we 
composed two large independent collections of invasive 
breast cancer cases from the Gerhard Domagk Institute of 
 Pathology, University of Münster (589 cases: collection 1), 
and the Institute of Pathology, Osnabrück (366 cases: 
 collection 2), containing invasive breast cancer cases 
graded from G1 to G3. All these cases were assembled 
on TMAs. The biological background of this analysis 
was the diagnostic/prognostic importance of cytokeratin 
(CK) expression patterns in physiological breast cells and 
invasive breast cancer cells, as can be seen in a multitude 
of publications throughout the last few years, eg, Abd 
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El-Rehim et al17 and Korsching et al.18 The measurements 
of the CKs were complemented by other factors known 
to play or supposed to play a role in this invasive cancer 
scenario.
Our objective was to (1) uncover the cooperativeness 
of the expression profiles of protein markers in a (patho)
physiological state of invasive breast cancer, (2) to show 
characteristics of the used TMA data giving clues to extract 
systematically more information from TMA data by con-
ventional means, (3) to support the reported tracer function 
of the CK expression in breast cancer progression, and (4) 
to analyze the properties of the measured data structure in 
more detail, to understand how cooperativeness is imprinted 
in the replicated expression data.
Methods
Ethics statement
Data were analyzed anonymously. Nonetheless, we con-
ducted this study according to the principles expressed in 
the Declaration of Helsinki. The study was approved by the 
Institutional Review Board of the University of Münster. 
We acquired tissue samples only with the informed consent 
of the patients or patients’ next of kin, with the understand-
ing by all parties that it may well be used for research. All 
patients provided written informed consent for the collection 
of samples and subsequent analysis.
Tissue samples
Two independent series of invasive breast cancer cases graded 
from G1 to G3 were used for this study. The clinicopathologi-
cal features of the patient samples can be seen in Table 1. 
Paraffin-embedded tissue of 589 invasive breast cancer 
cases, originating from the archives of the Gerhard Domagk 
Institute of Pathology, University of Münster  (collection 1) 
and 366 breast cancer cases originating from the archives 
of the Institute of Pathology, Osnabrück  (collection 2) were 
used for the production of a TMA in accordance with pub-
lished protocols (Kononen et al,19  Packeisen et al20). Each 
carcinoma was represented by two cores. The spot diameter 
was 0.6 mm. The distance between the spots was 1.0 mm. 
A specialized tissue array precision instrument (Beecher 
Instruments, Silver Spring, MD, USA) was used to assemble 
the TMA. Sections of 3 µm thickness were cut from the TMA 
blocks and stained. The average value of both cores was 
taken for further investigation. To enable the definition of 
representative tumor areas, a hematoxylin and eosin-stained 
section was made from each donor block. The tumor series 
represented all stages, grades, and histological subtypes of 
invasive breast cancer in accordance with the literature (data 
not shown here).
Staining procedures were done according to standard 
protocols. The pretreatment conditions, the source, and the 
dilution of the commercially available primary antibodies are 
listed in Table S1. The immunohistochemistry results were 
evaluated independently by two pathologists according to 
well-established scoring schemes.21
Data preprocessing
A certain number of measurements (7% for the first and 17% 
for the second collection, randomly distributed) missed the 
stringent evaluation scheme, or were lost during the staining 
procedure. The missing values in the data matrix were replaced 
with the median value of the remaining immunohistochemical 
values of that type. Some impact on the variance of the results 
can be estimated from Figure S2A (variance of the solid 
symbols). But presumably a much greater impact comes from 
the collectors and pathologists themselves. The choice of the 
median or the mean for missing values did not influence the 
final order of the test factors (details not presented).
Optimization algorithm
The goal of the presented algorithm (master plan, see  Figure 1, 
column A) is to construct an optimal rank order of a group of test 
factors for multiple reference situations. The rationale behind 
this is to stabilize the results by reducing the number of possibili-
ties to generate such a result. This is comparable to a scientist 
who is making a couple of different experiments and not only 
one to extract knowledge about the system of interest.
The algorithmic approach was developed based on two 
independent invasive breast cancer collections (Table 2). The 
data groups are further subdivided by the composition of 
measured and included molecular factors. This diversity was 
used first and foremost to evaluate the stability of the results. 
But some other considerations, like the impact of inserting 
molecular factors or assembling several dependency clusters, 
are also fostered by this experimental design. For validation 
purposes, it was important for us that some of the expression 
levels of the chosen factors and their regulatory dependencies 
were already described in the literature.22,17
Apart from the permutation parts, the algorithm is imple-
mented on the basis of the open-source statistical software 
R (www.r-project.org) and a Linux platform. The time-critical 
parts were implemented in Fortran (Fortran Compiler version 
11 for Linux. Intel, Santa Clara, CA, USA).
We start with a classical array representation of the data 
where the columns show the immunohistochemical variables 
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Table 1 Clinicopathological features of the patient samples
Tumor grade T-category N-category
All (n = 955)
 G1 = 163 
 G2 = 475 
 G3 = 317
T1a = 12 
T1b = 63 
T1c = 390 
T2 = 374 
T3 = 65 
T4 = 51
N negative = 544 
N positive = 411
Münster (n = 589)
 G1 = 111 
 G2 = 291 
 G3 = 187
T1a = 21 
T1b = 35 
T1c = 247 
T2 = 227 
T3 = 36 
T4 = 23
N negative = 312 
N positive = 277
Osnabrück (n = 366)
 G1 = 65 
 G2 = 175 
 G3 = 126
T1a = 7 
T1b = 25 
T1c = 150 
T2 = 142 
T3 = 25 
T4 = 17
N negative = 197 
N positive = 169
(factors) and the rows represent the analyzed individual 
samples (Figure 1, 1A). The factors are divided into a refer-
ence set and a test set (Figure 1, 2A). For the particular case 
where the CKs should be analyzed, the reference factors were 
filled with CK5, CK8/18, CK14, CK19, CK1, and CK10. 
Some of these CKs are known to discriminate subentities of 
invasive breast carcinomas. All the other factors belong to 
the test-factor group.
In the next step, a proximity measure is calculated 
between the reference and test candidates. Here we used 
the correlation according to Pearson.23 The reason for that 
choice is our interest in differentiating the long and complex 
immunohistochemical profiles of the measured biological 
factors (see Figure S1 for details of the effect).
The correlation cross-tabulation (Figure 1, 3A) with the 
n reference factors annotated on top and the m test factors 
annotated to the side is the basis of the following permutation 
procedure (Figure 1, 4A). The aim is to rank the m test factors 
in the n reference situations in a way that the global sum of the 
sum of squares (ssq
g
) of n linear regression approaches (one 
for each reference situation) will be minimized (Figure 2). 
The constraint is that the rank ordering of the m test factors 
is identical for all n situations and a certain permutation. 
The resulting best situation will describe the best observable 
dependency of the test factors to the ensemble of reference 
factors.
So in our case, we are not primarily interested in a 
single correlation value, but in an ensemble of correlation 
values and their optimal rank ordering under the constraint 
of an optimal fit to multiple targets (reference factors). 
Figure S2, C and D shows why the number of reference 
factors makes sense. The distance to a random situation 
will increase.
Tests of statistical significance
The statistical significance of our results was tested using 
resampling methods. The general procedure of such tests is 
that a superset of surrogate data sets is generated. The test 
statistic in question is then obtained for each of those new 
data sets, and the value of the test statistic of the original 
data set is checked against its distribution in the superset of 
surrogate data sets.
The distribution of the test statistic over the surrogate 
data superset corresponds to the null hypothesis that – given 
the constraints of the experiment – the observed value is due 
only to random fluctuations.
A test-statistic value for the original data set lying 
far in the tail of that distribution is a sign of high signifi-
cance, which can also be quantified using its position in 
the  distribution. The P-value obtained corresponds to the 
fraction of entries in that histogram that is still further 
from the bulk than the test-statistic value obtained from 
the original data set.
Surrogate data sets were generated using both the per-
mutation and the bootstrap methods.24,25 In permutation 
tests, the surrogate data sets are generated by randomly 
shuffling the complete original data set, thereby reproduc-
ing exactly the statistical distribution of the original data. 
In bootstrap testing, surrogate data sets are generated 
by randomly choosing data (with replacement) from the 
original data set, separately for each immunohistochemical 
factor. Here, the surrogate data sets reproduce the statisti-
cal distribution of the original data only on average. The 
idea behind the latter approach is that the original data 
set is already an heuristic approximation of the underly-
ing population the experiment is performed on. Thereby, 
fluctuations due to the stochastic nature of an experiment, 
ie, random observations from the underlying population, 
are accounted for, too.
Usually, we used a superset of 10+4 surrogate data sets, 
each of the original data set size, and we used both, permuta-
tion and bootstrap methods, in each case. The test statistic 
we computed in each case was the minimal ssq
g
 for a data 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
4
Buerger et al
Open Access Bioinformatics 2013:5
Antibodies
C
as
es
Raw data
n
Reference factors
m
T
es
t 
fa
ct
o
rs
Correlation
data
Optimization:
minimization of
global sum of sum of squares
ssq
Select
number and type
of reference factors
Test of the properties of the sample distribution: 
1) Random permutation of the complete matrix
     without replace
2) Bootstrap procedure per antibody with replace
Test of the properties of the combinatorial space:
1) Test all combinations n+m choose n
     for smallest global sum of squares
2) Test all combinations n+m. Choose n with
     the configuration which has the smallest global
     sum of sum of squares in the of original selection.
Verification procedures
on each level of the core workflow
1
2
3
4
Core workflow
Test of the properties of the sample distribution: 
1) Random permutation of the complete matrix
     without replace
2) Bootstrap procedure per reference factor
     with replace
g
Test of the biological relevance:
Comparing with observed dependencies 
BA
Figure 1 Block diagram of the algorithm and of the verification procedures.
Notes: This overview summarizes on the left the important core steps of the algorithm. The column on the right summarizes all the verification procedures as well as the 
additional analytic procedures. Column A: this flowchart explains the processing of the data from the initial raw-data matrix until the end of the permutation procedure. The 
main analysis is based on an a priory chosen set of biological factors – the cytokeratins. After raw-data processing, the data is collected in a two-dimensional matrix – patient 
cases versus factors (1A). The factors are subdivided in two groups: a test set and a reference set (2A). In the next step, the correlation is calculated for all combinations 
of the test and reference set (3A). Then, for each of the possible permutations of test factors, the global sum of the sum of squares (ssqg) for all the analyzed situations is 
calculated (4A). The situation with the minimal ssqg is used to choose the optimal rank order. Column B: here, the different verification procedures of the algorithm are 
presented. In (1B and 3B), two verifications will be performed on the data matrix: a permutation sampling approach of the complete raw-data or correlation matrix, and 
a bootstrap approach on factor columns of the raw-data matrix or reference-factor columns of the correlation matrix. In (2B), the spotlight is on all the possible group 
compositions of the size six of 16 giving insight into all the data properties, and in (4B) the biological relevance of the results will be discussed in relation to published data.
set, obtained from this data set’s optimal rank ordering, as 
described above.
Distribution of the minimal ssqg  
of different group compositions
We started the analysis with a selection of six CKs acting 
as reference factors. The remaining 10 factors were used 
as test factors. The CKs were selected as reference factors, 
because we already own independent a priory knowledge 
on their biological role. This opens up the opportunity to 
verify the behavior of the algorithm. But there are many 
other six of 16 partitions remaining. To get some insight 
into the whole dependency structure we analyzed also all 
these remaining six of 16 partitions. Every unique reference 
combination will result, as described above, in an optimal 
ssq
g
. The distribution of all best ssq
g
 will show the best 
six of 16 composition. This distribution was also analyzed 
according to the mode structure and stability.
The basic six of 16 approach was generalized to examine 
alternate numbers of reference factors on the same raw data set. 
The experiments ranged from reference group sizes of eight of 
16 to four of 16. The more extreme values below 4 were not 
feasible due to computing time constraints. Limited insight 
into the computing times is given in  supplementary Figure S3. 
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It has to be noted that the present limit is about 18–20 factors, 
assuming all permutations should be calculated.
Results
Definition of used raw data sets
The protein expression of 16 factors was examined, in the cells 
of interest, in invasive breast cancer cases from two pathologies 
(collection 1 and collection 2). The  measurements resulted in 
16 relative protein quantifications for each sample. Three of 
the antibodies differed between the two collectives; therefore, 
five basic situations were analyzed as depicted in Table 2.
Optimal rank ordering based on 
589 invasive breast cancer cases
Will the rank order of collection (M-16) reflect already-published 
measurements of other research groups? The  reference set com-
prises CK1, CK5, CK8/18, CK10, CK14, and CK19, known 
to be involved in breast cancer progression pathways. The test 
set was built by a couple of more or less prominent markers 
like the epidermal growth factor receptor (EGFR), vimentin, 
proliferation-related factor Ki-67 (antibody name MIB1), tumor 
suppressor p53, oncogene c-erb-B2, interacting mediator of cell 
death BCL2, cyclin D1, epithelial membrane antigen, proges-
terone receptor (PR), and estrogen receptor (ER).
The result of the optimization process is shown in 
Figure 3A1. The panel with the six plots, each illustrating 
one of the reference situations, represents the examined 
data in the state with the minimal ssq
g
 error. The resulting 
optimal rank order on the x-axis reflects the dependency of 
the test factors on the reference factors. In contrast to a pure 
ranking of correlation coefficients, the positions of several 
test factors were adjusted according to the fit for multiple 
reference situations. The final and high order for all factors 
can be seen in Figure 3A2.
Even though the individual correlation values might be 
rather low, a clear differential effect could be seen for CK5, 
CK14, CK19, and CK8/18, while the correlation values for 
CK1 and CK10 were rather low, and the respective regres-
sion lines did not show a clear tendency. These two CKs 
do not contribute to the differential behavior. Additionally, 
we can observe that the center positions of the optimal rank 
order of the test factors on the x-axis also do not contribute 
to the differential behavior. Only the extreme parts define 
the synergistic or antagonistic dependency.
Verification of the optimal rank ordering 
with an independent invasive breast  
cancer data collection
The verif ication was performed with collection O-16 
(Table 2). Thirteen of these antibodies are identical to those 
used in collection 1. The reference set comprises again CK1, 
CK5, CK8/18, CK10, CK14, and CK19. The test set  consists 
again of EGFR, vimentin, Ki-67 (MIB1), p53, erb-B2, PR, 
ER, and three different factors: CD 10, transcriptional modu-
lator p63, and smooth-muscle actin.
Three objectives were pursued: (1) how well does a 
smaller and independent invasive breast cancer sample col-
lective from a different pathology prove the results of the 
main collective, (2) to analyze whether and how different 
factors influence the result, and (3) how do the combina-
tion of the concordant measurements of the invasive breast 
cancer sample collectives behave. The optimal rank order 
of the independent breast cancer data collection is shown in 
Figure 3B1 and 2. The same basic principle as in  Figure 3A1 
from the first breast cancer data collection can be observed. 
There is a minor rearrangement of the sequence of the test 
factors on the x-axis due to the three different proteins in the 
test set. CK14 exhibits a weaker response. The higher ssq
g
 
value compared to Figure 3A2 might also reflect a higher het-
erogeneity of the sample collective and/or number of missing 
values. This is also apparent in Figure 3B2, where the order 
is not as clearly defined as in Figure 3A2. Nevertheless, the 
type of order is very similar to the first breast cancer data 
collection, and the strong effectors concerning the synergistic 
or antagonistic behavior remain the same.
To analyze the effect of the three different factors in more 
detail, we made for both breast cancer collections a design 
where the test set is reduced to the seven factors present in 
both collectives (Figure S4C and D, based on collections 
Table 2 Data groups
Acronym Groups Number  
of cases
Number  
of factors
Composition
(M-16) Münster 589 16 A and B
(O-16) Osnabrück 366 16 A and C
(M-13) Münster 589 13 A
(O-13) Osnabrück 366 13 A
(M + O-13) Münster and  
Osnabrück
955 13 A
Notes: Two different sample collections were used. The first set is based on 589 
cases of the pathology of Münster and the second on 366 cases of the pathology of 
Osnabrück, in total, 955 cases. With these two collections, several molecular markers 
were measured. A: CK1, CK10, CK5, CK14, CK8/18, CK19, vimentin, epidermal 
growth factor receptor, MIB1, erb-B2, p53, estrogen receptor, progesterone receptor; 
B: BCL2, cyclin D1, epithelial membrane antigen; C: smooth-muscle actin, p63, CD10. 
In the last column of the table, the composition of factors for each data group is 
indicated. The acronyms will be used throughout the publication.
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M-13 and O-13). The omission of three different factors from 
the test-set results in either case in a deletion in the center part 
of the optimal rank order, but does not alter the remainder. 
The effects on the overall structure are very small.
Joining both breast cancer data collections on the basis 
of the corresponding 13 factors (M + O-13) resulted in a 
similar outcome, as observed in the breast cancer collection 
M-13 (Figure S4E).
Despite all minor differences, which account to variations 
in the sample cohort, different numbers of missing values, and 
three different proteins, the analysis led to the same results 
in both invasive breast cancer collectives.
Data sets and their distributions
In this and the following sections, we analyze the structure 
and properties of the data sets more basically, to understand 
the principles behind how dependencies might model the 
given data structure.
First, we look at the distributions of the five basic analysis 
scenarios depicted in Table 2. In Figure 4, the primary ssq
g
 
distributions for collections M-16 and O-16 are presented. All 
possible orders contribute with one ssq
g
 to these distributions. 
Results for M-13, O-13, and M + O-13 can be seen in Figure S5. 
Depending on the number of ssq
g
 values, the smoothness of the 
distributions varies as well as the median. All five distributions 
of the respective ssq
g
 values share the same characteristic of a 
left-skewed distribution. The shape and height of the distribu-
tion is slightly different between the two sample collections. 
Also in these cases, an impact of the borderline cases, handled 
differently in both pathologies, and the effects from the three 
different proteins must be taken into consideration.
Analyzing the differences between  
the optimal rank ordering of the original  
data and the random and bootstrap  
samples of these data
These approaches should test whether or not the results are 
generated by chance. The optimization algorithm calculated 
a minimal ssq
g
 for each scenario of  Table 2. Disturbing the 
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Figure 2 Details of the optimization process and the optimal rank order.
Notes: This time-critical procedure was implemented with the Fortran Compiler version 11 for Linux (Intel, Santa Clara, CA, USA). Some of the Fortran routines are 
from the open-source Fortran library of John Burkardt. Here, a simplified version of the permutation procedure is presented. Two reference factors building two reference 
situations (symbolized by dark- and light-blue boxes) and three test factors (green, yellow, red boxes) are shown in three idealized permutation cycles. At each step, the 
global sum of the sum of squares (ssqg) gets smaller, ending up at a minimum (indicated to the right of each permutation step). On the x-axis, the permutations are shown. 
We start with permutation 1 (n = 2: cytokeratin [CK] 5/6 and CK8/18). The start point of the optimization process has the given order of the m test factors. For that rank 
ordering, a linear regression curve is calculated for each reference factor resulting in two sums of squares. The global sum of those sums (ssqg) is the decision value for the 
ongoing permutation procedure and should be optimized towards the lowest possible value. This is done in this example by choosing a new permutation of test factors. A 
new ssqg is calculated (see permutation 2). If this new result is smaller than the previous result, this new result will be stored together with the corresponding rank order. 
This process continues until all permutations (or the unique 50%) are tested (see permutation 3: idealized final and best state in our example). As “optimal rank ordering,” 
we consider the permutation that gives the smallest ssqg. The list of all permutations of the test factors is obtained by complete enumeration.
34
Abbreviations: EGFr, epidermal growth factor receptor; EMA, epithelial membrane antigen.
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Figure 3 The optimal caption dependency scheme for the main breast cancer data sets. 
Notes: The scatter plots on top of the figure are showing the values of the correlation on the y-axis according to each cytokeratin reference factor. The test factors are 
listed on the x-axis. For one panel, the rank order of the test factors is always identical (see the Methods section for exemplification). The upper end on the y-axis indicates 
a positive correlation, the lower end an inverse correlation. The order of the ten factors on the x-axis depicts the final optimal rank order according to the minimal ssqg 
of all regression lines. Cytokeratin (CK) 5/6 and CK8/18 represented the extremes with diametrical opposing regression lines. CK14 and 19 behave similarly compared to 
CK5/6 and CK8/18, respectively. reference situations exhibiting a moderate to high slope in the regression line show effects from the optimal rank ordering of the test 
factors positioned at the extremes of the x-axis, while reference situations exhibiting a small slope show that there is no effect at all. (A1) M-16; (B1) O-16. (A2) and (B2) 
are correspondingly showing a visualization of the (ordered) correlation matrices. Further graphs can be seen in supplementary Figure S3.
data matrix might therefore result in smaller (better) or 
greater (worse) ssq
g
 solutions. This will test how specific the 
generated results will be.
A sampling approach without replacement  (permutation) 
was performed on the complete data matrix, while the bootstrap 
approach (with replacement – approx 37%) was applied sepa-
rately for each protein staining (see Figure 1, 1B and 3B).
At first, we applied the approach on the level of the raw data. 
The result for the M-16 collection is very distinct.  Performing 
10+4 tests, all the permutation as well as the bootstrap results 
gave no smaller ssq
g
 value (P = 0, Figure 5A bootstrap, Figure 
S6A1 and 3). In the case of collection 2 with the seven match-
ing test factors, it behaves differently. A total of 250 of the 10+4 
tests resulted in a smaller ssq
g
 value (P = 0.025, respectively, 
P = 0.022, Figure 5B bootstrap, Figure S6B1 and 3). The 
combination of collection 1 with collection 2 on the basis of 
the seven matching test factors (M + O-13) resulted for the 
sampling approach in five smaller ssq
g
 values (P = 5 × 10–4).
Performing the approach as described on the level of the 
correlation data – permutation of the complete matrix or 
bootstrapping on the reference-factor columns – revealed 
very similar results. In Figure S6A2 and 4, the results for the 
M-16 collection are shown. There is no smaller ssq
g
 like in the 
raw-data analysis. Looking on collection O-13 (Figure S6B2 
and 4), the procedure generates again some smaller ssq
g
 
values (P = 0.024, respectively, P = 0.022).
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Notes: The distributions show all the possible global sum of sum of squares (ssqg) 
values generated by the permutation procedure. On the x-axis, the ssqg range is 
shown, while on the y-axis the normalized counts are plotted (total number of 
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spread of the distributions is different.
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Figure 5 Distributions of the verification analysis.
Notes: The distributions show all the possible global sum of the sum of squares 
(ssqg) values generated from the respective data sets applying a bootstrap approach 
to the original or the correlation data (compare Figure 1, 1B and 3B). On the x-axis, 
the ssqg range is shown, while on the y-axis the normalized density is plotted. 
(A) M-16; (B) O-16. In both cases, a bootstrap approach per factor on the raw-
data matrix is shown. Vertical lines show the position of the minimal ssqg of the 
performed bootstrap tests (min bootstrap) and the minimal ssqg from the analysis of 
the original unaltered data (min raw).
Collection M-16, with the CKs acting as reference fac-
tors, behaves, concerning the probability values, more ideally 
than collection O-13 and also the joint collection M + O-13. 
It makes no difference to apply sampling or bootstrapping 
procedures on the level of the raw as well on the level of the 
correlation data. In both levels, the data structure is very 
sensitive to disorganization. Testing the impact of the sample 
size on the specificity of the solution, we see that for the given 
data structure about 200 cases are necessary (Figure 6).
Analyzing different group compositions
Up to this point, we had chosen a special six of 16 partition of 
factors, representing our research focus on the CK  family. But 
additional (16 choose 6)-1 = 8007 other partitions are possible 
to distribute the factors between the test group of size 10 
and the reference group of size 6 (Figure 1, 2B). All these 
combinations represent different views on one and the same 
physiological situation and can be seen as a low-dimensional 
projection of the high-dimensional situation.
The question arises as to where our special group parti-
tion with its minimal ssq
g
 is located in the distribution of 
all possible (six of 16) group partitions. The result based on 
the data set M-16 (Figure 7A) shows a trimodal distribu-
tion. The vertical line denotes the position of our primary 
combination, which is located near the minimum between 
the left and the central mode. For the other data sets, this 
effect is not so clear, indicating an influence of the protein 
composition and/or the patient collective on the mode struc-
ture (Figure S7B–E).
We note that upon testing these results against a per-
mutation/bootstrap sampling of the raw or the correlation 
matrix, all the multimodal distributions change to unimodal 
distributions.
At this point, the question arises as to which mode the CK 
combination of reference factors might belong. The absolutely 
smallest ssq
g
 is obviously not linked with the CK reference.
We suspect that the trimodal distribution we are able 
to observe in collection M-16 represents a superposition of 
more than one regulatory context. Under this assumption, 
we should find that our composition should belong to the 
central mode. To test for this, we constructed all possible 
replacements of one group member in the primary set of six 
reference factors, resulting in 60 partitions. We obtained the 
distribution shown in Figure 7B. The original combination 
still has the smallest ssq
g
. Two replacements at a time (675 
partitions) resulted in the distribution shown in Figure 7C. 
The original combination is no longer the lower extreme of 
the subset in focus, but it is on the lower end of the main 
cluster of data.
It might be that the trimodal distribution depends on 
the group size of the test as well as the reference group 
and not from the underlying data composition. To test for 
this, we used again collection M-16, but with group sizes 
ranging from eight of eight to four of twelve (reference 
to test). Either CK1 and/or 10 were removed or cyclin D1 
and/or c-erb-B2 were added. In all situations, the trimodal 
characteristic remained stable (Figure S8). The maximal ssq
g
 
value shrank from eight of eight to four of twelve, as well as 
the modes losing their distinct appearance and proportions. 
This indicates that the mode formation is closely related to 
the structure of the data set, and not to the partitioning of the 
data in reference and test set.
These results illustrate two things: (1) the stability of the 
CK-based six of 16 composition (concerning the smallest 
ssq
g
) is limited to one exchange in the reference group, and 
(2) the modes are composed in a complex way by a super-
position of many six of 16 compositions.
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Discussion
The primary focus was put on (1) construction of an opti-
mal rank order of proteins reflecting their cooperative 
 phenomena, and the verification of certain results with 
the published data, and (2) to give a first draft on the 
imprinting of the cooperative phenomena in the given data 
structure. Guided by these objectives, we will discuss our 
procedure.
Design of the algorithmic procedure
The optimization algorithm is based on a couple of con-
straints, in our view being essential to analyze cooperative 
phenomena. This is not only true for tissue-array data, but 
more or less for all types of array data. The basic assumption 
is that a certain protein in a distinct physiological situation 
has a self-consistent set of relations to a certain number of 
other macromolecules. This is the basis to construct a rank 
order reflecting the synergistic, antagonistic, or independent 
behavior of a protein to other proteins. Secondly, we wanted 
to correct for noise in the system. This was done by construct-
ing the order by using several joined reference situations. 
In every situation, the protein must perform as optimally as 
possible. Therefore, we use the term “optimal” rank order. 
The local rearrangements of the correlation values to form 
the rank order illustrate this process. Another reason to use 
more than one reference situation is to raise the probability 
that the result is specific for a certain (patho)physiological 
situation. If a molecular factor has a distinct outcome in 
every reference situation, the determination is higher and the 
solution more stable.26
The reason we can decipher this optimal rank order by a 
correlation analysis of one physiological situation is that we 
have some variation in this state. The variation of 16  factors 
of one sample is not independent from the variation of 
16 factors in another sample. Because of the hidden systemic 
aspect, all the changes are coordinated. This coordination 
is imprinting systematic differences in the sample vectors. 
These differences will be exploited by the optimal rank order 
to reconstruct dependencies (Figure S1). This in turn means 
that in an ideal situation (a perfect homogeneous collection 
of samples), we would fail to detect dependencies with the 
Pearson correlation.
Generalizing this approach to any other array data type 
appears readily possible. Naturally, it will be necessary to 
adapt the procedure to other types of data, sources of data, 
and possibly different results and interpretations.
Of course, a limitation to this approach is the number of 
factors, which can be analyzed at once using the computer 
power available (rate of growth: factorial). We are working on 
overcoming this limitation by parallelizing the calculation as 
well as by reducing the combinatorial space. It seems, based 
on the analysis with three alternative molecular factors, that 
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Figure 6 The impact of the number of samples on the signal-to-noise distance.
Notes: The approach compares the bootstrap global sum of the sum of squares (ssqg) values (hollow symbols, red fit line) with best ssqg value of the given data (solid symbol, 
blue fit line). Reference and test factors remain unaltered throughout the experiment. In this figure, the M-16 data are presented. A linear downsizing of the full sample size 
(589) was performed. The plot shows the sample size (x-axis) against the respective ssqg values (y-axis). It can be clearly seen that below 200 samples, the signal-to-noise 
distance decreases, and finally the sampling and the basic results overlap.
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an assembly process mapping several overlapping analysis 
approaches together might be feasible.
Known protein dependencies can  
be confirmed and supplemented
The adult breast epithelium consists of differentiated luminal 
glandular and basal myoepithelial cells as well as undiffer-
entiated breast progenitor cells. In the basal compartment, 
the CK factors CK5, CK14, and smooth-muscle actin are 
coexpressed, while the CK8/18 are expressed in the mature 
luminal part. The invasive breast cancer is characterized by 
the expression of CK5, 14 and absence or the low occurrence 
of ER/PR/HER2. The mentioned factors can be seen therefore 
as markers for tumors originating from the respective regions 
and cellular differentiation stages. The other more weakly 
characterized factors used in this work might differentiate 
this picture by supporting one of the extremes or showing 
no specific participation.
CK5 and CK14, as well as CK8/18 and CK19, show a 
strong dependence on the optimal rank ordering of depen-
dencies determined between the test and reference factors. 
This is also once more reconfirmed by a recent study of 
Shao et al.27 However, the actual dependence of each pair of 
factors is diametrically opposite. No obvious trend could be 
defined for CK1 or CK10. These calculated dependencies 
are in accordance with protein-expression data described by 
Abd El-Rehim.17,28 Chen et al29 describe this inverse relation-
ship for vimentin, ER, and PR. The presented approach is 
well suited to extend the analytical approaches shown in, eg, 
Choo et al30 and Sarrió et al,31 because the expression values 
will be interconnected by an optimal order. The optimal rank 
order is a definite interpretation of the measured data under 
a given situation.
For carcinomas with expression of CK5 and CK14, our 
approach corresponds also on the morphological and clinical 
level with the published data.32
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Figure 7 Distribution of all group combinations and stability of the result against alterations of the groups.
Notes: (A) All six of 16 combinations of the collective M-16. (B) Subset of (A) generated by doing an exchange of one group member at once concerning the cytokeratin 
(CK) six of 16 combination. This means to exchange one CK(CK5/6, CK14, CK8/18, CK19, CK1, and CK10) of the reference group versus one of the test group. The CK 
combination remains the one with the smallest global sums of the sum of squares (ssqg). (C) Subset of (A) generated by doing an exchange of two group members at once. 
The cytokeratin combination is no longer the one with the smallest ssqg. (A–C) A line denotes the best ssqg of the six of 16 CK combination.
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Getting back to the examined collections, identical 
optimal rank orders could be detected in two completely 
independent collections of invasive breast cancer cases. We 
consider the procedure therefore reliable. The small devia-
tions in the slopes of the individual regression lines can be 
explained by the difference in the sizes of the two invasive 
breast cancer cohorts, and by their assembly in two different 
institutes. It is known that institutions usually differ slightly 
in the classification of borderline cases, leading to different 
case mixes in the collections used.
Furthermore, the procedure works constitutively. If new 
factors are added, they are inserted within the existing optimal 
rank ordering at certain positions, thereby refining this order, 
but preserving parts or modules of its previous structure.
The insertion of new factors, as shown with the col-
lection of the second institute of pathology, might have an 
impact on the distribution of the ssq
g
 of all six of 16 group 
compositions. There, the mode structure of the distribution 
might change due to the insertion of factors belonging to a 
different pathway situation.
Summarizing these observations, the approach is able 
to analyze the cooperative phenomena of several prominent 
and some weakly characterized proteins in breast cancer. 
The calculated results correspond perfectly with already 
published observations.
Implications resulting  
from the initial data type
The tissue microarray data referred to in this experimental 
setting consist of relative measurements per protein. The 
dependencies between the proteins are detected on the basis 
of the imprinted pattern of signal profiles of the observed 
proteins. This implies that we cannot make assumptions that 
are linked to absolute concentrations of the metabolites.
Permutation process and optimization  
of the rank order
The permutation procedure is used to analyze the complete 
combinatorial space of protein dependencies to find the 
most likely dependency order given by the set of array 
 measurements. When differences between a true and a 
wrong order are small, errors in a measurement may have a 
profound impact on the resulting rank order. Thus, simple 
sorting of correlation values might not lead to a true rank 
order. To correct for this effect, the rank order will be opti-
mized by multiple reference situations. Test and reference 
set are generated by partitioning the protein measurements 
into two groups.
The number of reference factors (or reference situations), 
n, can vary. In the limiting case of one reference factor, we 
have a trivial ranking, and the correlation value is the only sur-
rogate measure for the dependency. Not the thing we intend. 
If n . 1, we are able to construct in the case of n + m = even: 
z = (m + n)/2 or in the case n + m = odd: z = (m + n – 1)/2 group 
size partitions. The partitions n . 1 do correct for errors. If 
n is growing towards z/2, the ssq
g
 range will become smaller 
and the modes will overlap strongly. We have analyzed this 
effect from n = 4/m = 12 to n = 8/m = 8 and see an acceptable 
operating point for the six of 16 partition, taking into consid-
eration the computing time and the biological interest.
The permutation sampling and the bootstrap con-
trols reveal no difference and show the specificity of the 
process.
If entities broaden up too much, as seen in the collec-
tion of the second pathology, the controls will show this 
by exposing some better ssq
g
 values. This can be seen as a 
vital control system proving if the heterogeneity/quality of 
the presented system is acceptable and whether calculations 
can be performed.
Analyzing all the group compositions  
of the data set
The analysis of all partitions gives a comprehensive insight 
into the dependency scenario, resulting in a trimodal distribu-
tion of the minimal ssq
g
 values of each analyzed partition. It 
can be supposed that these three groups in the distribution 
might reflect three superimposed dependency structures, so 
the within-group dependency is higher than the between-
group dependency. This is underlined by the observation 
that a randomization of the raw measurements or correlation 
values will show a change of the observed trimodal distribu-
tion to a monomodal distribution. Following this concept, 
we may find at the lower end of the respective peaks the 
respective optimal solutions for each individual dependency 
structure. The dependency between the networks is reflected 
by the portion of overlap in the distributions tested by the 
construction of all possible replacements of one group mem-
ber in the primary set of six reference factors. The stability 
can be shown for one replacement at a time.
The assumption that this might reflect a superposition of 
three major dependency structures remains to be justified in 
a further study with real data and simulated data.
Conclusion
The algorithm is able to extract an optimal rank order of test 
factors in a given reference-factor situation. This optimal rank 
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order can be interpreted as a complete net of dependencies 
between all the analyzed 16 factors. The process needs 
neither additional information nor any constraints beyond the 
given immunohistochemical measurements. The definition 
of an initial grouping is not mandatory. The experimental 
investigator gets therefore an exciting procedure for their 
TMA experiments.
For research on invasive breast cancer, this study adds 
some interesting details on the interaction of the CKs with a 
couple of other biological factors, and invites the testing of a 
lot more factors with this combinatorial procedure.
As a side effect, this approach is also able to test if marker 
panels are relevant and specific for clinical classification pur-
poses. An advanced application of the algorithm in a clinical 
setting is given in Schymik et al33 illustrating the versatility 
of the approach.
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different. It is essential for the reliability of the algorithm to have a situation where (a) profiles show variance and (b) the number of cases is great enough to show a specific 
outcome in the optimization procedure (for this issue cf. Figure 3 and supplementary Figure 2). Note that the Pearson correlation is comparing variances not intensity levels.
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Figure S2 The impact of the number of samples and reference factors on the signal to noise distance.
Notes: Four situations - including the Figure 3 of the main publication - will be presented. (A) and (B) are illustrating the impact of the sample size on the specificity of the 
result. The impact is analyzed by applying (A) a random sub selections on the full sample size or (B) by linearly downsizing the full sample size. (A) is therefore showing more 
fluctuations than (B). The signal to noise distance is stable at a sample size of greater 200. (C and D) are analyzing in a similar way the impact of the number of reference factors. 
The number of samples is fixed. (C) shows the raw analysis while (D) shows a normalized version of (C). Normalization was performed by division through the number of 
chosen reference factors. (A–D) In all graphs the M-16 data is presented. The bootstrap ssqg values (hollow symbols, red fit line) will be compared with the best ssqg value of 
the given data (solid symbol, blue fit line). (A, B) reference and test factors remain unaltered throughout the experiment. Both plots show the sample size (x-axis) against the 
respective ssqg values (y-axis). (A) A linear downsizing of the full sample size (589) was performed. It can be clearly seen, that below 200 samples the signal to noise distance 
decreases and finally the results overlap. (B) Like in (A) a downsizing of the full sample size was performed. But at every step the reduced sample was randomly drawn from the 
full set of 589 samples (‘random pick’, uniform distribution). The variance is more prominent. This is also a good indicator on how stable results are if different compositions 
of samples are tested. Nevertheless also in this approach, 200 samples remain a good estimate for generating a stable result. (C and D) The sample size remains constant 
(589 cases). The reference factors (all cytokeratins) were stepwise reduced from 6 to 2. The test factors remain unaltered. (C) shows the raw results while (D) shows the 
normalized version. Both results clearly demonstrate that also in this perspective a higher number of reference factors enlarge the signal to noise distance.
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Figure S3 Computing time constraints of the algorithm.
Notes: A runtime comparison based on an example job is shown. 8008 combinations with 6 reference factors out of a total of 16 factors were calculated using some different 
implementations of the program. The first column from the left represents the implementation, which was used to establish the algorithm and to calculate the presented 
results. The columns to the right show some ongoing development. The gain is to be up to 1600 times faster compared to the original implementation. But the real challenge 
is to invest more work in theoretical concepts to select the informative areas of the combinatorial space.
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Figure S4 The optimal dependency scheme for all breast cancer data sets.
Notes: This figure corresponds to Figure 3 (and is including Figure 3). The plots are showing the correlation (y-axis) according to each reference factor while the test 
factors are listed on the x axis. For a reference group the order of test factors is always identical (see Methods for exemplification). The order of the test factors on the x 
axis represents the final optimal rank order. Cytokeratins 5/6 and 8/18 represented the extremes with diametrical opposing regression lines. CK 14 and 19 behave similar 
compared to CK 5/6 and CK 8/18, respectively. reference situations exhibiting a moderate to high slope in the regression line show effects from the optimal rank ordering 
of the test factors positioned at the extremes of the x axis, while reference situations exhibiting a small slope show that there is no effect at all. (A1) M 16, (B1) O-16, (C1) 
M-13, (D1) O-13 and (E1) M+O-13. The corresponding graphs on the next page show a visualization of the (optimal ordered) correlation matrices.
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Figure S5 Basic distributions of all 5 analyzed data sets.
Notes: The distributions show all the possible ssqg generated from the 5 basic data sets. On the x-axis the ssqg range is shown, while on the y-axis the normalized counts are 
plotted (total number of counts is 1). (A) M-16, (B) O-16, (C) M-13, (D) O-13 and (E) M+O-13. Depending on the 6 number of factors a different number of permutations 
is possible: (A and B) 3.6*106, (C–E) 5040. Obviously the fluctuations grow for smaller numbers of permutations.
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Figure S6 Distributions of the verification analysis.
Notes: The distributions show all the possible ssqg values generated from the respective data sets applying a bootstrap or a permutation sampling to the original or the 
correlation data (compare Figure 1-1b,3b). On the x axis the ssqg range is shown, while on the y axis the counts are plotted. A1-A4 M-16: (1) bootstrap approach per 
factor on the raw data, (2) bootstrap approach per reference factor on the correlation data, (3) permutation approach on the complete raw matrix, (4) permutation 
approach on the complete correlation matrix. B1-B4 O-13: (1) bootstrap approach per factor on the raw data, (2) bootstrap approach per reference factor on the 
correlation data, (3) permutation approach on the complete raw matrix, (4) permutation approach on the complete correlation matrix. Vertical lines show the position 
of the minimal ssqg of the performed sampling tests (min. bootstrap or min. permutation sampling), and the minimal ssqg from the analysis of the unaltered data (min. raw) 
respectively (min. corM) for sampling on the level of the correlation matrix.
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Figure S8 Testing the variability of the trimodal distribution by altering the size of the reference and test set. 
Notes: On the x-axis the ssqg range is shown, while on the y-axis the counts are plotted. The analysis is based on collection M-16. The group size was varied from (A) 8 
reference/8 test members to (E) 4 reference/12 test members. ‘ssq min.’ respective ‘max.’ denote the ssqg spread of the distribution. On top the number of combinations 
building the distribution is noted.
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Figure S7 Distribution of all combinations for all 5 collections.
Notes: On the x-axis the ssqg range is shown, while on the y-axis the counts are plotted. (A) M-16, (B) O-16, (C) M-13, (D) O-13 and (E) M+O-13. ‘min. ssq sel. part.’ means: 
Minimal ssqg of the a priory chosen cytokeratin combination. ‘ssq min.’ respective ‘max.’ denote the ssqg spread of the distribution.
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Table S1 Pretreatment conditions, source, and dilution of primary antibodies used for the immunohistochemical staining
Antibody Source Clone Pretreatment (min) Dilution C
CK1 Novocastra 34ßB4 S (30) Citrate buffer 1:150 1 + 2
CK5 Dako D5/16B4 S (10) Citrate buffer 1:80 1 + 2
CK8/18 Dianova 5D3 S (10) Citrate buffer 1:40 1 + 2
CK10 Dako DE-K10 S (30) Citrate buffer 1:400 1 + 2
CK14 Dianova LL002 S (30) Citrate buffer 1:50 1 + 2
CK19 Quartett KS19.1 S (30) Citrate buffer 1:80 1 + 2
Er Novocastra 6F11 S (10) 1:30 1 + 2
Pr Novocastra 16 S (10) 1:200 1 + 2
Ki-67 Dako MIB-1 S (10) Citrate buffer 1:40 1 + 2
c-erb-B2 Dako [polyclonal] S (30) Citrate buffer 1:400 1 + 2
EGFr Ventana 3C6 S (10) Citrate buffer 1:100 1 + 2
Vimentin Ventana V9 S (30) Citrate buffer 1:1000 1 + 2
SMA Dako A14 S (30) Citrate buffer 1:4000 2
CD10 Novocastra 56C6 S (30) Citrate buffer 1:40 2
p53 Dako DO-7 S (10) Citrate buffer 1:500 1 + 2
p63 Dako 4A4 S (30) Citrate buffer 1:100 2
BCL2 Dako 124 S (30) Citrate buffer 1:500 1
Cyclin D1 NeoMarkers SP4 S (30) Citrate buffer 1:25 1
EMA Dako E29 S (30) Citrate buffer 1:2000 1
Notes: “C” denotes if the antibody was used with collection 1 (“1”) or with collection 2 (“2”) or in both collections (“1 + 2”). In the Pretreatment column, S means steamer.
Abbreviations: Er, estrogen receptor; Pr, progesterone receptor; SMA, smooth-muscle actin; EMA, epithelial membrane antigen.
Reference
1. Pearson K. Determination of the coefficient of correlation. Science. 
1909;30(757):23–25.
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